Annual banned-substance review: analytical approaches in human sports drug testing.

Frequently updated anti-doping regulations and detection strategies for banned substances and methods of doping are vital for efficient and scientifically substantiated abatement of drug abuse, manipulation, and illicit performance enhancement in sport. In 2012, the ninth version of the Prohibited List as annually issued by the World Anti-Doping Agency (WADA) reports on modest but relevant modifications from its 2011 predecessor. Awareness of old and new analytical challenges in sports drug testing, together with issues resulting from altered rules and regulations, have given rise to numerous research projects aiming at improved detection strategies to strengthen international anti-doping efforts. In this annual banned substance review, emerging and advancing methods in the detection of known and recently outlawed substances are reported. New and/or enhanced procedures and techniques of doping analysis are reviewed together with information relevant to doping controls. The review surveys and critiques literature published between October 2011 and September 2012.

[1]  M. Baumstark,et al.  Reticulocytes in athletes: Longitudinal aspects and the influence of long- and short-term exercise. , 2010, Drug testing and analysis.

[2]  Nicolas V. Schwab,et al.  Mass spectrometry made easy: the quest for simplicity. , 2013, Drug testing and analysis.

[3]  J. Schulze,et al.  Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism. , 2015, Drug testing and analysis.

[4]  M. Thevis,et al.  Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls. , 2013, Drug testing and analysis.

[5]  Torben Pottgiesser,et al.  Biomarker monitoring in sports doping control. , 2012, Bioanalysis.

[6]  F. Agosti,et al.  Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes. , 2009, European journal of endocrinology.

[7]  M. Mazzarino,et al.  Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control , 2011, Analytical and bioanalytical chemistry.

[8]  C. Reichel Recent developments in doping testing for erythropoietin , 2011, Analytical and bioanalytical chemistry.

[9]  Pierre-Edouard Sottas,et al.  Hemoglobin mass and biological passport for the detection of autologous blood doping. , 2012, Medicine and science in sports and exercise.

[10]  S. Kageyama,et al.  Analysis of non-ketoic steroids 17alpha-methylepithiostanol and desoxymethyl- testosterone in dietary supplements. , 2009, Drug testing and analysis.

[11]  M. Thevis,et al.  Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. , 2011, Rapid communications in mass spectrometry : RCM.

[12]  Ó. Pozo,et al.  New potential markers for the detection of boldenone misuse , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  M. Thevis,et al.  Detection of His-tagged Long-R³-IGF-I in a black market product. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[14]  Gangfeng Ouyang,et al.  Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. , 2012, Journal of chromatography. A.

[15]  M. Thevis,et al.  Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. , 2010, Rapid communications in mass spectrometry : RCM.

[16]  M. Galésio,et al.  Comparative study of matrices for their use in the rapid screening of anabolic steroids by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[17]  M. Aşırdizer,et al.  Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey. , 2013, Journal of forensic and legal medicine.

[18]  J. Schulze,et al.  Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men. , 2011, The Journal of clinical endocrinology and metabolism.

[19]  Eileen Y. Robertson,et al.  Within-subject variation in hemoglobin mass in elite athletes. , 2012, Medicine and science in sports and exercise.

[20]  Ó. Pozo,et al.  Stability of selected chlorinated thiazide diuretics. , 2009, Journal of pharmaceutical and biomedical analysis.

[21]  D. Gerrard Drug misuse in sport: a historical perspective. , 2015, The New Zealand medical journal.

[22]  Wilhelm Schänzer,et al.  Mass Spectrometry-Based Characterization of New Drugs and Methods of Performance Manipulation in Doping Control Analysis , 2010, European journal of mass spectrometry.

[23]  C. Saudan,et al.  Validation and performance comparison of two carbon isotope ratio methods to control the misuse of androgens in humans. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  P. Van Eenoo,et al.  Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis. , 2008, Journal of chromatography. A.

[25]  M. Thevis,et al.  Identification of fibroblast growth factor 1 (FGF-1) in a black market product. , 2011, Drug testing and analysis.

[26]  M. Meyer,et al.  Analytical Toxicology of Emerging Drugs of Abuse—An Update , 2012, Therapeutic drug monitoring.

[27]  Serge Rudaz,et al.  Sample preparation development and matrix effects evaluation for multianalyte determination in urine. , 2009, Journal of pharmaceutical and biomedical analysis.

[28]  M. Thevis,et al.  Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing , 2013, Analytical and Bioanalytical Chemistry.

[29]  M. Nielen,et al.  Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of-flight mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[30]  S. Catalano,et al.  Nandrolone and stanozolol induce leydig cell tumor proliferation through an estrogen‐dependent mechanism involving IGF‐I system , 2012, Journal of cellular physiology.

[31]  R. Heltsley,et al.  Screening indicators of dehydroepiandosterone, androstenedione, and dihydrotestosterone use: a literature review. , 2011, Journal of analytical toxicology.

[32]  M. Thevis,et al.  Dried blood spots (DBS) for doping control analysis , 2011 .

[33]  Ó. Pozo,et al.  Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection. , 2009, Journal of chromatography. A.

[34]  S. Anker,et al.  The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats , 2013, Journal of cachexia, sarcopenia and muscle.

[35]  D. Eichner,et al.  Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport , 2013, Analytical and Bioanalytical Chemistry.

[36]  M. Nielen,et al.  High-throughput bioaffinity mass spectrometry for screening and identification of designer anabolic steroids in dietary supplements. , 2013, Analytical chemistry.

[37]  F. Lucidi,et al.  A call for policy guidance on psychometric testing in doping control in sport. , 2015, The International journal on drug policy.

[38]  P. Hemmersbach,et al.  Nandrolone: a multi-faceted doping agent. , 2010, Handbook of experimental pharmacology.

[39]  Jaeick Lee,et al.  Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control. , 2015, Drug testing and analysis.

[40]  Mai M H Mansour,et al.  The hunt for gene dopers. , 2009, Drug testing and analysis.

[41]  L. King,et al.  New phenethylamines in Europe. , 2014, Drug testing and analysis.

[42]  M. Thevis,et al.  Metabolism of growth hormone releasing peptides. , 2012, Analytical chemistry.

[43]  K. Deventer,et al.  Development of a sensitive GC-C-IRMS method for the analysis of androgens. , 2013, Biomedical chromatography : BMC.

[44]  Pierre-Edouard Sottas,et al.  Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study , 2011, Transfusion.

[45]  C. Thompson New ESA to be available for dialysis patients. , 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[46]  Generic sample preparation combined with high-resolution liquid chromatography–time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories , 2010, Analytical and bioanalytical chemistry.

[47]  M. Thevis,et al.  Temporal indication of cannabis use by means of THC glucuronide determination. , 2009, Drug testing and analysis.

[48]  N. Bachl,et al.  Why Glucocorticosteroids Should Remain in the List of Prohibited Substances: A Sports Medicine Viewpoint , 2012, International journal of immunopathology and pharmacology.

[49]  J. Pawliszyn,et al.  Determination of cocaine and methadone in urine samples by thin-film solid-phase microextraction and direct analysis in real time (DART) coupled with tandem mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.

[50]  J. Yli-Kauhaluoma,et al.  Synthesis and Characterization of Hydroxylated Mesocarb Metabolites for Doping Control , 2009, Archiv der Pharmazie.

[51]  Ó. Pozo,et al.  Steroid metabolism in chimeric mice with humanized liver. , 2009, Drug testing and analysis.

[52]  R. Ventura,et al.  Masking and manipulation. , 2010, Handbook of experimental pharmacology.

[53]  C. Reichel,et al.  Erythropoietin and analogs. , 2010, Handbook of experimental pharmacology.

[54]  P. Sönksen,et al.  Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection , 2013, Analytical and Bioanalytical Chemistry.

[55]  C. Reichel The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. , 2011, Drug testing and analysis.

[56]  D. Spandidos,et al.  Applications and Biomonitoring Issues of Recombinant Erythropoietins for Doping Control , 2011, Therapeutic drug monitoring.

[57]  P. Kavanagh,et al.  Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. , 2013, Journal of analytical toxicology.

[58]  J. Brugniaux,et al.  Hemoglobin and hematocrit are not such good candidates to detect autologous blood doping , 2009, International journal of hematology.

[59]  Carsten Lundby,et al.  Reticulocyte profile in top-level alpine skiers during four consecutive competitive seasons , 2010, European Journal of Applied Physiology.

[60]  M. Thevis,et al.  Zeranol: doping offence or mycotoxin? A case-related study. , 2011, Drug testing and analysis.

[61]  M. Schäfer,et al.  Structure Elucidation of the Diagnostic Product Ion at m/z 97 Derived from Androst-4-en-3-One-Based Steroids by ESI-CID and IRMPD Spectroscopy , 2012, Journal of The American Society for Mass Spectrometry.

[62]  M. Thevis,et al.  Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls , 2010, Analytical and bioanalytical chemistry.

[63]  Serge Rudaz,et al.  Analytical aspects in doping control: challenges and perspectives. , 2011, Forensic science international.

[64]  K. Gundersen,et al.  A cellular memory mechanism aids overload hypertrophy in muscle long after an episodic exposure to anabolic steroids , 2013, The Journal of physiology.

[65]  A. Petróczi,et al.  Effects of Dietary Components on Testosterone Metabolism via UDP-Glucuronosyltransferase , 2013, Front. Endocrinol..

[66]  S. Bornstein,et al.  Pilot Study of Serum Inhibin B as a Potential Marker of Testosterone Doping in Weight Lifting Men , 2010, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[67]  U. Mareck,et al.  Investigations on changes in ¹³C/¹²C ratios of endogenous urinary steroids after pregnenolone administration. , 2011, Drug testing and analysis.

[68]  A. George,et al.  Carbon isotope ratio (δ13C) values of urinary steroids for doping control in sport , 2009, Steroids.

[69]  Wilhelm Schänzer,et al.  Factors influencing the steroid profile in doping control analysis. , 2008, Journal of mass spectrometry : JMS.

[70]  Darío Cuervo,et al.  An automated sample preparation for detection of 72 doping-related substances. , 2014, Drug testing and analysis.

[71]  A. Bauer,et al.  Characterization of identity, metabolism and androgenic activity of 17-hydroxyandrosta-3,5-diene by GC–MS and a yeast transactivation system , 2012, Archives of Toxicology.

[72]  J. Veuthey,et al.  Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: Confirmatory analysis. , 2010, Journal of chromatography. A.

[73]  T. Hervig,et al.  Blood doping: the flip side of transfusion and transfusion alternatives. , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[74]  Ó. Pozo,et al.  Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism. , 2009, Drug testing and analysis.

[75]  C. Saudan,et al.  Profiling of 19-norandrosterone sulfate and glucuronide in human urine: Implications in athlete's drug testing , 2009, Steroids.

[76]  M. Koupparis,et al.  Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[77]  U. Stenman,et al.  Determination of human chorionic gonadotropin. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[78]  W. Banks,et al.  Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases , 2015, The AAPS Journal.

[79]  N. Baume,et al.  Influences of β-HCG administration on carbon isotope ratios of endogenous urinary steroids , 2012, Steroids.

[80]  K. Ho,et al.  Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm. , 2009, Drug testing and analysis.

[81]  M. Thevis,et al.  Clenbuterol - regional food contamination a possible source for inadvertent doping in sports. , 2012, Drug testing and analysis.

[82]  P. Marques‐Vidal,et al.  Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations. , 2011, Forensic science international.

[83]  R. Holt Detecting growth hormone misuse in athletes , 2013, Indian journal of endocrinology and metabolism.

[84]  D. Wells Gene doping: possibilities and practicalities. , 2009, Medicine and sport science.

[85]  M. Thevis,et al.  Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes. , 2011, Journal of mass spectrometry : JMS.

[86]  A. Nieß,et al.  Direct and long-term detection of gene doping in conventional blood samples , 2011, Gene Therapy.

[87]  A. Cohen,et al.  Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk–benefit , 2013, British journal of clinical pharmacology.

[88]  M. Thevis,et al.  Detection of recombinant growth hormone in human plasma by a 2‐D PAGE method , 2008, Electrophoresis.

[89]  G. Lippi,et al.  Controlling sources of preanalytical variability in doping samples: challenges and solutions. , 2013, Bioanalysis.

[90]  A. Amoresano,et al.  Qualitative screening in doping control by MALDI-TOF/TOF mass spectrometry: a proof-of-evidence. , 2012, Journal of pharmaceutical and biomedical analysis.

[91]  J. Veuthey,et al.  Analysis of hemoglobin‐based oxygen carriers by CE‐UV/Vis and CE‐ESI‐TOF/MS , 2010, Electrophoresis.

[92]  A. Elbe,et al.  The Urine Marker Test: An Alternative Approach to Supervised Urine Collection for Doping Control , 2015, Sports Medicine.

[93]  D. Kwiatkowska,et al.  Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose. , 2015, Journal of pharmaceutical and biomedical analysis.

[94]  B. Garrido,et al.  Detection of designer steroid methylstenbolone in “nutritional supplement” using gas chromatography and tandem mass spectrometry: Elucidation of its urinary metabolites , 2013, Steroids.

[95]  R. Boet,et al.  Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage. , 2012, Annals of emergency medicine.

[96]  M. Ashenden,et al.  Screening for Autologous Blood Transfusions , 2009, International journal of sports medicine.

[97]  J. V. Sancho,et al.  Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses. , 2011, Journal of chromatography. A.

[98]  C. Gore,et al.  Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport , 2011, Journal of Clinical Pathology.

[99]  J. V. Sancho,et al.  Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry , 2009, Steroids.

[100]  Grigory Rodchenkov,et al.  Detection of JWH-018 metabolites in smoking mixture post-administration urine. , 2010, Forensic science international.

[101]  Neil Robinson,et al.  The athlete biological passport: an effective tool in the fight against doping. , 2011, Clinical chemistry.

[102]  N. Robinson,et al.  A high-throughput test to detect C.E.R.A. doping in blood. , 2009, Journal of pharmaceutical and biomedical analysis.

[103]  N. Robinson,et al.  Effects of Exercise on the Isoelectric Patterns of Erythropoietin , 2009, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[104]  P. Hemmersbach,et al.  Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples. , 2015, Drug testing and analysis.

[105]  M. Minunni,et al.  Transgene traceability in transgenic mice: a bioanalytical approach for potential gene-doping analysis. , 2011, Bioanalysis.

[106]  G. Thiene,et al.  Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. , 2012, Forensic science international.

[107]  J. Schulze,et al.  Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes , 2013, European journal of clinical investigation.

[108]  Yorck Olaf Schumacher,et al.  Scientific expertise and the Athlete Biological Passport: 3 years of experience. , 2012, Clinical chemistry.

[109]  M. Thevis,et al.  Glycerol administration before endurance exercise: metabolism, urinary glycerol excretion and effects on doping-relevant blood parameters. , 2014, Drug testing and analysis.

[110]  L. Reubsaet,et al.  Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males , 2013, Analytical and Bioanalytical Chemistry.

[111]  Mario Zorzoli,et al.  Implementation of the biological passport: the experience of the International Cycling Union. , 2010, Drug testing and analysis.

[112]  M. Baron,et al.  Keeping pace with NPS releases: fast GC-MS screening of legal high products. , 2013, Drug testing and analysis.

[113]  Wilhelm Schänzer,et al.  Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. , 2011, Drug testing and analysis.

[114]  Mai M H Mansour,et al.  Gene doping: of mice and men. , 2009, Clinical biochemistry.

[115]  M. Thevis,et al.  Comprehensive plasma-screening for known and unknown substances in doping controls. , 2010, Rapid communications in mass spectrometry : RCM.

[116]  Ó. Pozo,et al.  Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. , 2010, Rapid communications in mass spectrometry : RCM.

[117]  D. Gould,et al.  Gene doping: Olympic genes for Olympic dreams , 2011, Journal of the Royal Society of Medicine.

[118]  Xinxiang Zhang,et al.  Quantification of testosterone and epitestosterone in biological samples by capillary electrophoresis with immunoaffinity extraction. , 2009, Talanta.

[119]  Mingshe Zhu,et al.  First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry , 2013, The AAPS Journal.

[120]  C. Georgakopoulos,et al.  The effect of fasting during Ramadan on parameters of the haematological and steroidal modules of the athletes biological passport - a pilot study. , 2015, Drug testing and analysis.

[121]  J. Mørkeberg Detection of autologous blood transfusions in athletes: a historical perspective. , 2012, Transfusion medicine reviews.

[122]  Leo N. Geppert,et al.  Validity of stable isotope data in doping control: perspectives and proposals. , 2012, Drug testing and analysis.

[123]  M. Irie,et al.  20K-GH and its use in detecting GH abuse. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[124]  Carsten Lundby,et al.  Blood doping and its detection. , 2011, Blood.

[125]  D. Glez-Peña,et al.  Speeding up the screening of steroids in urine: Development of a user-friendly library , 2013, Steroids.

[126]  G. Lippi,et al.  Ex vivo erythrocyte generation and blood doping. , 2013, Blood transfusion = Trasfusione del sangue.

[127]  R. Holt,et al.  Detecting growth hormone abuse in athletes , 2011, Analytical and bioanalytical chemistry.

[128]  V. Backer,et al.  The Pharmacokinetic Profile of Inhaled and Oral Salbutamol in Elite Athletes With Asthma and Nonasthmatic Subjects , 2012, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[129]  M. Thevis,et al.  Liquid Chromatography-High Resolution/High Accuracy (Tandem) Mass Spectrometry-Based Identification of in vivo Generated Metabolites of the Selective Androgen Receptor Modulator ACP-105 for Doping Control Purposes , 2014, European journal of mass spectrometry.

[130]  A. Lesiak,et al.  DART-MS for rapid, preliminary screening of urine for DMAA. , 2014, Drug testing and analysis.

[131]  K. Ho,et al.  Growth Hormone in Sports: Detecting the Doped or Duped , 2011, Hormone Research in Paediatrics.

[132]  Gongke Li,et al.  A novel protocol for molecularly imprinted polymer filaments online coupled to GC-MS for the determination of androgenic steroids in urine. , 2013, Journal of separation science.

[133]  A. Kniess,et al.  Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports. , 2013, Journal of pharmaceutical and biomedical analysis.

[134]  C. Gore,et al.  Detraining Decreases Hbmass of Triathletes , 2012, International Journal of Sports Medicine.

[135]  Ó. Pozo,et al.  Current status and bioanalytical challenges in the detection of unknown anabolic androgenic steroids in doping control analysis. , 2013, Bioanalysis.

[136]  N. Baume,et al.  SARM-S4 and metabolites detection in sports drug testing: a case report. , 2011, Forensic science international.

[137]  Christopher R Harrison,et al.  Towards the identification of autologous blood transfusions through capillary electrophoresis , 2013, Analytical and Bioanalytical Chemistry.

[138]  Andrew T Kicman,et al.  Biochemical and physiological aspects of endogenous androgens. , 2010, Handbook of experimental pharmacology.

[139]  G. Leroux-Roels,et al.  Metabolic studies with promagnon, methylclostebol and methasterone in the uPA+/+-SCID chimeric mice , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[140]  R. Dierckx,et al.  Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging , 2012, European journal of clinical investigation.

[141]  D. Andreu,et al.  Alterations of the erythrocyte membrane proteome and cytoskeleton network during storage--a possible tool to identify autologous blood transfusion. , 2012, Drug testing and analysis.

[142]  M. Thevis,et al.  Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. , 2015, Drug testing and analysis.

[143]  K. Ho,et al.  Growth hormone administration: is it safe and effective for athletic performance. , 2010, Endocrinology and metabolism clinics of North America.

[144]  E. Callaway Sports doping: Racing just to keep up , 2011, Nature.

[145]  F. S. Rojas,et al.  Recent developments in analytical determination of furosemide. , 2008 .

[146]  Elliot R. Cooper,et al.  In Vitro Androgen Bioassays as a Detection Method for Designer Androgens , 2013, Sensors.

[147]  R. Plumb,et al.  Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the quantification of ephedrines using medium-resolution accurate mass spectrometry. , 2013, Journal of chromatography. A.

[148]  M. Thevis,et al.  Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing. , 2013, Rapid communications in mass spectrometry : RCM.

[149]  J. Wuestenfeld,et al.  Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes. , 2010, Endocrinology and metabolism clinics of North America.

[150]  M. Mascini,et al.  Simultaneous detection of transgenic DNA by surface plasmon resonance imaging with potential application to gene doping detection. , 2011, Analytical chemistry.

[151]  S. Rzeppa,et al.  Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry. , 2015, Drug testing and analysis.

[152]  M. Hsu,et al.  Determination of raloxifene in urine by liquid chromatography-tandem mass spectrometry for doping. , 2013, Journal of analytical toxicology.

[153]  M. Thevis,et al.  Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer , 2012, Analytical and Bioanalytical Chemistry.

[154]  T. Friedmann,et al.  Gene Doping and Sport , 2010, Science.

[155]  Yasuhiko Takahashi,et al.  A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate. , 2013, European journal of pharmacology.

[156]  Nathalie A. Desrosiers,et al.  Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? , 2014, Clinical chemistry.

[157]  U. Flenker Isotope ratio mass spectrometry - history and terminology in brief. , 2012, Drug testing and analysis.

[158]  H. Peyrière,et al.  Misuse of anabolic products in sport: a retrospective study of phone calls at the Écoute Dopage anti-doping hot-line. , 2013, Therapie.

[159]  R. Ventura,et al.  Determination of five di-(2-ethylhexyl)phthalate metabolites in urine by UPLC-MS/MS, markers of blood transfusion misuse in sports. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[160]  M. Nielen,et al.  Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres , 2013, Analytical and Bioanalytical Chemistry.

[161]  H. Lieberman,et al.  Analysis of 1,3 dimethylamylamine concentrations in Geraniaceae, geranium oil and dietary supplements. , 2014, Drug testing and analysis.

[162]  J. Schulze,et al.  The Impact of Genetics and Hormonal Contraceptives on the Steroid Profile in Female Athletes , 2014, Front. Endocrinol..

[163]  E. Virus,et al.  'Wrong-way-round ionization' and screening for doping substances in human urine by high-performance liquid chromatography/orbitrap mass spectrometry. , 2012, Journal of mass spectrometry : JMS.

[164]  J. Pinkstaff,et al.  Comparison of bioanalytical methods for the quantitation of PEGylated human insulin. , 2013, Journal of immunological methods.

[165]  M. Thevis,et al.  Application of FAIMS to anabolic androgenic steroids in sport drug testing. , 2009, Drug testing and analysis.

[166]  K. Carlsen,et al.  Exercise and asthma: an overview , 2015, European clinical respiratory journal.

[167]  L. Delgado,et al.  Impact of Changes in Anti-doping Regulations (WADA Guidelines) on Asthma Care in Athletes , 2013, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[168]  M. Thevis Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays , 2010 .

[169]  David Handelsman,et al.  Effects of recombinant human LH and hCG on serum and urine LH and androgens in men , 2009, Clinical endocrinology.

[170]  M. Thevis,et al.  Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation. , 2012, Journal of pharmaceutical and biomedical analysis.

[171]  M. Thevis,et al.  Doping control analysis of trenbolone and related compounds using liquid chromatography–tandem mass spectrometry , 2009, Steroids.

[172]  U. Mareck,et al.  13C/12C ratios of endogenous urinary steroids investigated for doping control purposes. , 2009, Drug testing and analysis.

[173]  R. Roškar,et al.  Determination of raloxifene and its glucuronides in human urine by liquid chromatography-tandem mass spectrometry assay. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[174]  J. Schulze,et al.  Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. , 2008, The Journal of clinical endocrinology and metabolism.

[175]  K. Deventer,et al.  Doping control analysis of desmopressin in human urine by LC-ESI-MS/MS after urine delipidation. , 2013, Biomedical chromatography : BMC.

[176]  M. Thevis,et al.  Mass spectrometric detection of peginesatide in human urine in doping control analysis. , 2012, Journal of pharmaceutical and biomedical analysis.

[177]  Monica Mazzarino,et al.  Screening and confirmation analysis of stimulants, narcotics and beta-adrenergic agents in human urine by hydrophilic interaction liquid chromatography coupled to mass spectrometry. , 2011, Journal of chromatography. A.

[178]  G. Vollmer,et al.  Detection of anabolic steroid abuse using a yeast transactivation system , 2008, Steroids.

[179]  J. Simmchen,et al.  Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios. , 2011, Drug testing and analysis.

[180]  M. Saugy,et al.  Recent developments in the use of isotope ratio mass spectrometry in sports drug testing , 2011, Analytical and bioanalytical chemistry.

[181]  C. Reichel Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion. , 2012, Drug testing and analysis.

[182]  F. Botrè,et al.  Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[183]  E Eryl Bassett,et al.  Statistical issues in implementing the marker method. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[184]  P. Dou,et al.  Immuno-magnetic beads-based extraction-capillary zone electrophoresis-deep UV laser-induced fluorescence analysis of erythropoietin. , 2012, Journal of chromatography. A.

[185]  J. Baker,et al.  Potential benefits of recombinant human growth hormone (rhGH) to athletes. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[186]  J. Kopchick,et al.  Perspective: proteomic approach to detect biomarkers of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[187]  F. Gosetti,et al.  Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[188]  M. Thevis,et al.  Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. , 2011, Drug testing and analysis.

[189]  M. Thevis,et al.  Mass spectrometry-based analysis of IGF-1 and hGH. , 2010, Handbook of experimental pharmacology.

[190]  IEF pattern classification‐derived criteria for the identification of epoetin‐δ in urine , 2010, Electrophoresis.

[191]  M. Duclos Glucocorticoids: a doping agent? , 2010, Endocrinology and metabolism clinics of North America.

[192]  Martial Saugy,et al.  Circulating miRNAs: a new generation of anti-doping biomarkers , 2013, Analytical and Bioanalytical Chemistry.

[193]  H. Geyer,et al.  Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes , 2010, Steroids.

[194]  P. Simon,et al.  Detection of EPO gene doping in blood. , 2012, Drug testing and analysis.

[195]  M. Thevis,et al.  Quantification of urinary AICAR concentrations as a matter of doping controls , 2010, Analytical and bioanalytical chemistry.

[196]  P. Sönksen,et al.  A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[197]  M. Thevis,et al.  Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testing. , 2012, Drug testing and analysis.

[198]  M. Thevis,et al.  RNA interference for performance enhancement and detection in doping control. , 2011, Drug testing and analysis.

[199]  M. Thevis,et al.  Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing , 2012, Analytical and Bioanalytical Chemistry.

[200]  R. Robergs,et al.  Identifying plasma glycerol concentration associated with urinary glycerol excretion in trained humans. , 2011, Journal of analytical toxicology.

[201]  Erin E. Chambers,et al.  Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma. , 2014, Analytical chemistry.

[202]  J. Hale,et al.  Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia , 2010, Expert opinion on therapeutic patents.

[203]  Y. Angelis,et al.  Current status and recent advantages in derivatization procedures in human doping control. , 2015, Bioanalysis.

[204]  P. Sönksen,et al.  The GH-2004 project: the response of IGF1 and type III pro-collagen to the administration of exogenous GH in non-Caucasian amateur athletes. , 2010, European journal of endocrinology.

[205]  R. L. Hilderbrand High-performance sport, marijuana, and cannabimimetics. , 2011, Journal of analytical toxicology.

[206]  N. Robinson,et al.  Procedures for monitoring recombinant erythropoietin and analogs in doping. , 2010, Endocrinology and metabolism clinics of North America.

[207]  Irene C. Perez,et al.  PCR-based detection of gene transfer vectors: application to gene doping surveillance , 2013, Analytical and Bioanalytical Chemistry.

[208]  G. Jacobson,et al.  Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscle. , 2014, Drug testing and analysis.

[209]  Weiling Fu,et al.  rhEPO/EPO discrimination with ultrasensitive electrochemical biosensor based on sandwich-type nano-Au/ZnO sol-gel/nano-Au signal amplification. , 2013, Biosensors & bioelectronics.

[210]  H. Geyer,et al.  Detection of Δ6-methyltestosterone in a "dietary supplement" and GC-MS/MS investigations on its urinary metabolism. , 2011, Toxicology letters.

[211]  W. Jelkmann,et al.  Intolerability of cobalt salt as erythropoietic agent. , 2014, Drug testing and analysis.

[212]  M. Thevis,et al.  Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. , 2013, Drug testing and analysis.

[213]  G. Lippi,et al.  Improvement in sprint performance: doping or nature? , 2013, Drug testing and analysis.

[214]  M. Bidlingmaier New detection methods of growth hormone and growth factors. , 2012, Endocrine development.

[215]  Y. Goda,et al.  Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. , 2010, Forensic science international.

[216]  Martial Saugy,et al.  Prevalence of blood doping in samples collected from elite track and field athletes. , 2011, Clinical chemistry.

[217]  A. E. Lima-Silva,et al.  Impaired Physical Performance and Clinical Responses after a Recreational Bodybuilder's Self-Administration of Steroids: A Case Report , 2015, The world journal of men's health.

[218]  Kuei-Hui Chan,et al.  Urinary elimination of ephedrines following administration of the Traditional Chinese Medicine preparation Kakkon-to. , 2008, Journal of analytical toxicology.

[219]  J. Lademann,et al.  Optical Coherent Tomography for in vivo Determination of Changes in Hair Cross Section and Diameter during Treatment with Glucocorticosteroids – A Simple Method to Screen for Doping Substances? , 2008, Skin Pharmacology and Physiology.

[220]  D. Armstrong,et al.  1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? , 2012, Drug testing and analysis.

[221]  J. Dvořák,et al.  Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts , 2012, British Journal of Sports Medicine.

[222]  G. Gmeiner,et al.  Screening of testosterone esters in human plasma. , 2013, Drug testing and analysis.

[223]  V. Backer,et al.  Combined inhalation of beta2‐agonists improves swim ergometer sprint performance but not high‐intensity swim performance , 2014, Scandinavian journal of medicine & science in sports.

[224]  M. Farré,et al.  Urinary metabolic profile of 19-norsteroids in humans: glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol. , 2008, Rapid communications in mass spectrometry : RCM.

[225]  J. Schulze,et al.  Non-Steroidal Anti-Inflammatory Drugs Do Not Influence the Urinary Testosterone/Epitestosterone Glucuronide Ratio , 2013, Front. Endocrinol..

[226]  P. Eenoo,et al.  Development of a GC/C/IRMS method – Confirmation of a novel steroid profiling approach in doping control , 2012, Steroids.

[227]  J. Christiansen,et al.  Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections ☆ ☆☆ ★: Implications for detection of GH abuse , 2010 .

[228]  F. Botrè,et al.  A simplified procedure for GC/C/IRMS analysis of underivatized 19-norandrosterone in urine following HPLC purification , 2011, Steroids.

[229]  F. A. Neto,et al.  Screening for hydroxyethyl starch (HES) doping in sport. , 2010, Journal of science and medicine in sport.

[230]  M. Ashenden,et al.  Improved alignment of reticulocyte counts between Sysmex XT-2000i instruments , 2012, Journal of Clinical Pathology.

[231]  C. Georgakopoulos,et al.  External calibration in gas chromatography-combustion-isotope ratio mass spectrometry measurements of endogenous androgenic anabolic steroids in sports doping control. , 2011, Journal of chromatography. A.

[232]  P. O'Malley The drive to win and never grow old: the risks of anabolic steroid abuse, an update for the clinical nurse specialist. , 2013, Clinical nurse specialist CNS.

[233]  D. Bruns,et al.  Circulating microRNA as a biomarker of human growth hormone administration to patients. , 2014, Drug testing and analysis.

[234]  Ó. Pozo,et al.  Sensitive and robust method for anabolic agents in human urine by gas chromatography-triple quadrupole mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[235]  V. Lopez-Avila,et al.  Identification of methylhexaneamine by GC high-resolution TOFMS and soft ionization. , 2013, Forensic science international.

[236]  C. Gore,et al.  Stability of athlete passport parameters during extended storage , 2013, International journal of laboratory hematology.

[237]  Ó. Pozo,et al.  Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis. , 2012, Drug testing and analysis.

[238]  R. Kostiainen,et al.  Analysis of anabolic steroids in urine by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry with chlorobenzene as dopant. , 2013, Journal of chromatography. A.

[239]  M. Saugy,et al.  A one-year monitoring of nicotine use in sport: frontier between potential performance enhancement and addiction issues. , 2011, Forensic science international.

[240]  S. Han,et al.  Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS. , 2012, Journal of pharmaceutical and biomedical analysis.

[241]  N. Baume,et al.  Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. A.

[242]  A. Petróczi,et al.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids , 2010, Substance abuse treatment, prevention, and policy.

[243]  C. Lundby,et al.  Assessment of total haemoglobin mass: can it detect erythropoietin-induced blood manipulations? , 2009, European Journal of Applied Physiology.

[244]  L. James,et al.  Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. , 2013, Analytical chemistry.

[245]  X. de la Torre,et al.  A comprehensive procedure based on gas chromatography-isotope ratio mass spectrometry following high performance liquid chromatography purification for the analysis of underivatized testosterone and its analogues in human urine. , 2012, Analytica chimica acta.

[246]  Jordi Segura,et al.  Current strategic approaches for the detection of blood doping practices. , 2011, Forensic science international.

[247]  V. Backer,et al.  High‐dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men , 2012, Scandinavian journal of medicine & science in sports.

[248]  Martial Saugy,et al.  The athlete biological passport. , 2011, Clinical chemistry.

[249]  A. George,et al.  Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control. , 2009, Drug testing and analysis.

[250]  M. Saugy,et al.  Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept. , 2012, Drug testing and analysis.

[251]  W. Schänzer,et al.  Sports-related issues and biochemistry of natural and synthetic anabolic substances. , 2010, Endocrinology and metabolism clinics of North America.

[252]  L. Reubsaet,et al.  Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis. , 2013, Bioanalysis.

[253]  J. Kelly,et al.  Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. , 2011, Drug testing and analysis.

[254]  M. Rondon,et al.  Impaired Post Exercise Heart Rate Recovery in Anabolic Steroid Users , 2013, International Journal of Sports Medicine.

[255]  M. Pfaffl,et al.  The analysis of the transcriptome as a new approach for biomarker development to trace the abuse of anabolic steroid hormones. , 2011, Drug testing and analysis.

[256]  M. Thevis,et al.  Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes. , 2009, Rapid communications in mass spectrometry : RCM.

[257]  B. Sporer,et al.  Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists , 2013, British Journal of Sports Medicine.

[258]  M. Thevis,et al.  Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators. , 2010, Handbook of experimental pharmacology.

[259]  D. Catlin,et al.  Enrichment and immunoprecipitation of 22 kDa human growth hormone spiked into human urine. , 2009, Drug testing and analysis.

[260]  A. Cawley Stable isotope ratio analysis in sports anti-doping. , 2012, Drug testing and analysis.

[261]  R. Donovan,et al.  Young athletes' awareness and monitoring of anti‐doping in daily life: Does motivation matter? , 2015, Scandinavian journal of medicine & science in sports.

[262]  W. Schänzer,et al.  Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates. , 2012, Drug testing and analysis.

[263]  C. Reichel OMICS-strategies and methods in the fight against doping. , 2011, Forensic science international.

[264]  A. Butch,et al.  Genetic variations in UDP-glucuronosyl transferase 2B17: implications for testosterone excretion profiling and doping control programs. , 2008, Clinical chemistry.

[265]  K. Langohr,et al.  Effect of physical fitness and endurance exercise on indirect biomarkers of growth hormone and insulin misuse: Immunoassay-based measurement in urine samples. , 2010, Journal of pharmaceutical and biomedical analysis.

[266]  T. Haahtela,et al.  Asthma Medication Is Increasingly Prescribed for Finnish Olympic Athletes—For a Reason? , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[267]  J. Tabet,et al.  Urine ratio of tetrahydrocortisol to tetrahydrodeoxycortisol to screen for the systemic administration of cortisone and hydrocortisone. , 2009, Forensic science international.

[268]  Guonan Chen,et al.  Determination of diuretics in human urine by hollow fiber-based liquid-liquid-liquid microextraction coupled to high performance liquid chromatography. , 2008, The Analyst.

[269]  C. Reichel,et al.  SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control. , 2009, Drug testing and analysis.

[270]  B. Venhuis,et al.  A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. , 2014, Drug testing and analysis.

[271]  W. Young,et al.  Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping. , 2008, Exercise immunology review.

[272]  M. Thevis,et al.  Urinary excretion of exogenous glycerol administration at rest. , 2011, Drug testing and analysis.

[273]  M. Mazzarino,et al.  Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies , 2013, Analytical and Bioanalytical Chemistry.

[274]  V. Backer,et al.  Asthma in elite athletes , 2011, Expert review of respiratory medicine.

[275]  S. Theocharis,et al.  Doping and musculoskeletal system: short‐term and long‐lasting effects of doping agents , 2011, Fundamental & clinical pharmacology.

[276]  M. Thevis,et al.  High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach. , 2011, Drug testing and analysis.

[277]  M. Koller,et al.  Carbon isotope ratio determination and investigation of seized testosterone preparations. , 2011, Drug testing and analysis.

[278]  K. High,et al.  Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges , 2011, Nature Reviews Genetics.

[279]  M. Marco,et al.  Multiplexed immunoassay to detect anabolic androgenic steroids in human serum , 2012, Analytical and Bioanalytical Chemistry.

[280]  A. George,et al.  Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping. , 2012, Drug testing and analysis.

[281]  F. Lasne Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. , 2015, Methods in molecular biology.

[282]  G. De Paoli,et al.  Naphyrone: analytical profile of the new "legal high" substitute for mephedrone. , 2011, Journal of forensic and legal medicine.

[283]  J. Capelo,et al.  Accelerated sample treatment for screening of banned doping substances by GC–MS: ultrasonication versus microwave energy , 2011, Analytical and bioanalytical chemistry.

[284]  O. Rabin,et al.  Investigating the use of stimulants in out-of-competition sport samples. , 2011, Journal of analytical toxicology.

[285]  M. Thevis,et al.  Metabolism of human insulin after subcutaneous administration: A possible means to uncover insulin misuse. , 2015, Analytica chimica acta.

[286]  M. Thevis,et al.  Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. , 2012, Journal of chromatography. A.

[287]  R. Holt Is human growth hormone an ergogenic aid? , 2009, Drug testing and analysis.

[288]  T. Rosén,et al.  A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health , 2013, British Journal of Sports Medicine.

[289]  W. Schänzer,et al.  CYP21-catalyzed production of the long-term urinary metandienone metabolite 17β-hydroxymethyl-17α-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping , 2010, Biological chemistry.

[290]  R. Ventura,et al.  Evaluation of immunoassays for the measurement of insulin and C-peptide as indirect biomarkers of insulin misuse in sport: values in selected population of athletes. , 2009, Journal of pharmaceutical and biomedical analysis.

[291]  Ó. Pozo,et al.  uPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study. , 2009, Clinical chemistry.

[292]  R. Baxter,et al.  Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[293]  N. Robinson,et al.  Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse. , 2011, Drug testing and analysis.

[294]  Moutian Wu,et al.  Detection of clenbuterol at trace levels in doping analysis using different gas chromatographic-mass spectrometric techniques. , 2013, Journal of chromatographic science.

[295]  J. Carlsson,et al.  Rapid detection of erythropoiesis-stimulating agents in urine and serum. , 2012, Analytical biochemistry.

[296]  M. Thevis,et al.  Proteolysis and autolysis of proteases and the detection of degradation products in doping control. , 2009, Drug testing and analysis.

[297]  A. Beotra,et al.  Detection of mono-hydroxylated metabolites of stanozolol by HPLC-ESI (+) MS/MS in Indian sports persons. , 2009, Drug testing and analysis.

[298]  M. Thevis,et al.  Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing , 2011, Analytical and bioanalytical chemistry.

[299]  Kuei-Hui Chan,et al.  Oxethazaine as the source of mephentermine and phentermine in athlete's urine. , 2009, Forensic science international.

[300]  Ó. Pozo,et al.  Quantitative Detection of Inhaled Salmeterol in Human Urine and Relevance to Doping Control Analysis , 2011, Therapeutic drug monitoring.

[301]  M. Gütschow,et al.  Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS. , 2009, Drug testing and analysis.

[302]  H. Yoo,et al.  Characterization of In Vitro Metabolites of CP 47,497, a Synthetic Cannabinoid, in Human Liver Microsomes by LC‐MS/MS , 2013, Journal of forensic sciences.

[303]  E. Virus,et al.  Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine. , 2012, Drug testing and analysis.

[304]  C. Fernández-Pérez,et al.  Impact of UGT2B17 gene deletion on the steroid profile of an athlete , 2015, Physiological reports.

[305]  M. Cowley,et al.  Detection of growth hormone doping by gene expression profiling of peripheral blood. , 2009, The Journal of clinical endocrinology and metabolism.

[306]  C. Lundby,et al.  Novel serum biomarkers for erythropoietin use in humans: a proteomic approach. , 2011, Journal of applied physiology.

[307]  P. Sönksen,et al.  Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport. , 2010, The Journal of clinical endocrinology and metabolism.

[308]  G. Bouguen,et al.  Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers , 2011, European Journal of Applied Physiology.

[309]  D. Kwiatkowska,et al.  Problems of the Use of Pseudoephedrine by Athletes , 2009, International journal of sports medicine.

[310]  H. Schwarzenbach Impact of physical activity and doping on epigenetic gene regulation. , 2011, Drug testing and analysis.

[311]  A. Petróczi,et al.  Analysis of anabolic steroids in human hair using LC–MS/MS , 2010, Steroids.

[312]  L Avois,et al.  Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis. , 2009, Journal of chromatography. A.

[313]  P. Eenoo,et al.  Profiling of urinary formestane and confirmation by isotope ratio mass spectrometry , 2013, Steroids.

[314]  M. Thevis,et al.  Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. , 2015, Drug testing and analysis.

[315]  A. Casilli,et al.  Analytical challenges in doping control: Comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option. , 2009, Journal of chromatography. A.

[316]  C. Reichel,et al.  SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood. , 2009, Drug testing and analysis.

[317]  A. George,et al.  The detection of androstenedione abuse in sport: a mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite. , 2008, Rapid communications in mass spectrometry : RCM.

[318]  David Handelsman,et al.  Immunoreactive LH in long-term frozen human urine samples. , 2014, Drug testing and analysis.

[319]  A. Bergmann,et al.  High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. , 2009, Clinical chemistry.

[320]  R. Heltsley,et al.  Prevalence of synthetic cannabinoids in U.S. athletes: initial findings. , 2012, Journal of analytical toxicology.

[321]  M. Thevis,et al.  Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. , 2010, Drug testing and analysis.

[322]  X. de la Torre,et al.  Rapid screening of beta-adrenergic agents and related compounds in human urine for anti-doping purpose using capillary electrophoresis with dynamic coating. , 2009, Journal of separation science.

[323]  P. Lantéri,et al.  Data-handling strategies for metabonomic studies: example of the UHPLC-ESI/ToF urinary signature of tetrahydrocannabinol in humans , 2014, Analytical and Bioanalytical Chemistry.

[324]  A. Prakash,et al.  Targeted Selected Reaction Monitoring Mass Spectrometric Immunoassay for Insulin-like Growth Factor 1 , 2013, PloS one.

[325]  Patricia L. Ranaivo,et al.  Analysis and Confirmation of 1,3-DMAA and 1,4-DMAA in Geranium Plants Using High Performance Liquid Chromatography with Tandem Mass Spectrometry at ng/g Concentrations , 2012, Analytical chemistry insights.

[326]  Ó. Pozo,et al.  Detection of urinary markers for thiazide diuretics after oral administration of hydrochlorothiazide and altizide-relevance to doping control analysis. , 2009, Journal of chromatography. A.

[327]  M. Thevis,et al.  Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105. , 2013, Rapid communications in mass spectrometry : RCM.

[328]  Wilhelm Schänzer,et al.  Current role of LC-MS(/MS) in doping control , 2007, Analytical and bioanalytical chemistry.

[329]  J. Dvořák,et al.  Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. , 2013, Drug testing and analysis.

[330]  E. Mayatepek,et al.  Adolescent ischemic stroke associated with anabolic steroid and cannabis abuse , 2013, Journal of pediatric endocrinology & metabolism : JPEM.

[331]  Bu Hz,et al.  A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: structure-kinetics relationship assessment. , 2006 .

[332]  Ó. Pozo,et al.  Urinary profile of methylprednisolone and its metabolites after oral and topical administrations , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[333]  D. Barceloux,et al.  Anabolic-androgenic steroids. , 2013, Disease-a-month : DM.

[334]  W. Hopkins,et al.  Variability of Serum Markers of Erythropoiesis during 6 Days of Racing in Highly Trained Cyclists , 2013, International Journal of Sports Medicine.

[335]  Beverly L. Davidson,et al.  Current prospects for RNA interference-based therapies , 2011, Nature Reviews Genetics.

[336]  J. Coombes,et al.  Performance benefits of rehydration with intravenous fluid and oral glycerol. , 2012, Medicine and science in sports and exercise.

[337]  M. Thevis,et al.  Stimulants and doping in sport. , 2010, Endocrinology and metabolism clinics of North America.

[338]  X. de la Torre,et al.  Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[339]  P. Marriott,et al.  Application of comprehensive two-dimensional gas chromatography to sterols analysis. , 2008, Journal of chromatography. A.

[340]  A. Ouellet,et al.  A simplified and accurate method for the analysis of urinary metabolites of testosterone-related steroids using gas chromatography/combustion/isotope ratio mass spectrometry. , 2013, Rapid communications in mass spectrometry : RCM.

[341]  Irene van den Broek,et al.  Current trends in mass spectrometry of peptides and proteins: Application to veterinary and sports-doping control. , 2015, Mass spectrometry reviews.

[342]  Ying Dong,et al.  Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes. , 2011, The Analyst.

[343]  K. Deventer,et al.  Specific screening method for dextran and hydroxyethyl starch in human urine by size exclusion chromatography–in-source collision-induced dissociation–time-of-flight mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[344]  Toyoki Mori,et al.  Bronchodilating Effect and Anabolic Effect of Inhaled Procaterol , 2008, International journal of sports medicine.

[345]  Stefan E Franz,et al.  Erythropoiesis-stimulating agents: development, detection and dangers. , 2009, Drug testing and analysis.

[346]  D. Gould Gene doping: gene delivery for olympic victory , 2013, British journal of clinical pharmacology.

[347]  D. Cowan,et al.  Doping in sport—2. Quantification of the impurity 19-norandrostenedione in pharmaceutical preparations of norethisterone , 2009, Steroids.

[348]  D. Volmer,et al.  Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection. , 2012, Drug testing and analysis.

[349]  Aaron C. T. Smith,et al.  Why the war on drugs in sport will never be won , 2015, Harm Reduction Journal.

[350]  N. Robinson,et al.  The effect of a period of intensive exercise on the isoform test to detect growth hormone doping in sports. , 2013, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[351]  P. Sönksen,et al.  Influence of ethnicity on IGF‐I and procollagen III peptide (P‐III‐P) in elite athletes and its effect on the ability to detect GH abuse , 2009, Clinical endocrinology.

[352]  M. Parr,et al.  Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system , 2011, Archives of Toxicology.

[353]  P. Sottas,et al.  Are 10 min of seating enough to guarantee stable haemoglobin and haematocrit readings for the athlete's biological passport? , 2010, International journal of laboratory hematology.

[354]  C. Cren-olivé,et al.  Comparison of the analysis of beta-blockers by different techniques. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[355]  M. Thevis,et al.  Meta-analysis: Effects of glycerol administration on plasma volume, haemoglobin, and haematocrit. , 2013, Drug testing and analysis.

[356]  A. Garnham,et al.  Current markers of the Athlete Blood Passport do not flag microdose EPO doping , 2011, European Journal of Applied Physiology.

[357]  C. Ayotte Detecting the administration of endogenous anabolic androgenic steroids. , 2010, Handbook of experimental pharmacology.

[358]  X. de la Torre,et al.  Speeding up the process urine sample pre-treatment: some perspectives on the use of microwave assisted extraction in the anti-doping field. , 2010, Talanta.

[359]  S. Rennard,et al.  PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease , 2012, Clinical pharmacology and therapeutics.

[360]  T. Friedmann How Close Are We to Gene Doping? , 2010, The Hastings Center report.

[361]  M. Thevis,et al.  Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. , 2013, Bioanalysis.

[362]  T. McDade Development and validation of assay protocols for use with dried blood spot samples , 2014, American journal of human biology : the official journal of the Human Biology Council.

[363]  I. McGregor,et al.  Exercise increases plasma THC concentrations in regular cannabis users. , 2013, Drug and alcohol dependence.

[364]  M. Thevis,et al.  Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. , 2011, Drug testing and analysis.

[365]  A. Brailsford,et al.  Two-dimensional gas chromatography with heart-cutting for isotope ratio mass spectrometry analysis of steroids in doping control. , 2012, Drug testing and analysis.

[366]  Keita Saito,et al.  Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. , 2010, Journal of pharmaceutical and biomedical analysis.

[367]  D. Poirier,et al.  Characterization of desoxymethyltestosterone main urinary metabolite produced from cultures of human fresh hepatocytes , 2012, Steroids.

[368]  Y. Dehnes,et al.  Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections. , 2013, Drug testing and analysis.

[369]  S. Hahner,et al.  Dehydroepiandrosterone to enhance physical performance: myth and reality. , 2010, Endocrinology and metabolism clinics of North America.

[370]  R. Bloomer,et al.  Safety profile of caffeine and 1,3-dimethylamylamine supplementation in healthy men , 2013, Human & experimental toxicology.

[371]  H. Sumnall,et al.  Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones. , 2011, Drug testing and analysis.

[372]  D. Catlin,et al.  The Influence of Diet on Isotope Ratio Mass Spectrometry Values , 2009, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[373]  K. Deventer,et al.  Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. , 2012, Analytica chimica acta.

[374]  K. Deventer,et al.  Qualitative detection of desmopressin in plasma by liquid chromatography–tandem mass spectrometry , 2012, Analytical and Bioanalytical Chemistry.

[375]  J. Auwerx,et al.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. , 2008, Cell metabolism.

[376]  D. Eichner,et al.  A population study of urine glycerol concentrations in elite athletes competing in North America. , 2013, Drug testing and analysis.

[377]  Ilkka Ojanperä,et al.  Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control , 2012, Analytical and Bioanalytical Chemistry.

[378]  K. Haupt,et al.  Toward the use of a molecularly imprinted polymer in doping analysis: selective preconcentration and analysis of testosterone and epitestosterone in human urine. , 2010, Analytical chemistry.

[379]  H. Maurer,et al.  Identification and differentiation of beta-blockers and their metabolites in urine by computerized gas chromatography-mass spectrometry. , 1986, Journal of chromatography.

[380]  S. Kageyama,et al.  Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application. , 2011, Drug testing and analysis.

[381]  Osquel Barroso,et al.  Detection of GH abuse in sport: Past, present and future. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[382]  M. Giacca,et al.  Enhanced athletic performance on multisite AAV-IGF1 gene transfer coincides with massive modification of the muscle proteome. , 2012, Human gene therapy.

[383]  B. Sellergren,et al.  Glucuronide directed molecularly imprinted solid-phase extraction: isolation of testosterone glucuronide from its parent drug in urine. , 2012, The Analyst.

[384]  M. Buemi,et al.  Does erythropoietin always win? , 2014, Current medicinal chemistry.

[385]  D. Cowan,et al.  Laboratory issues in the implementation of the marker method. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[386]  K. Deventer,et al.  Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine. , 2012, Journal of pharmaceutical and biomedical analysis.

[387]  M. Saugy,et al.  Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing , 2013, Analytical and Bioanalytical Chemistry.

[388]  M. Koupparis,et al.  Stabilization of human urine doping control samples: a current opinion , 2011, Analytical and bioanalytical chemistry.

[389]  A. Petróczi,et al.  Dietary green and white teas suppress UDP-glucuronosyltransferase UGT2B17 mediated testosterone glucuronidation , 2012, Steroids.

[390]  U. Flenker,et al.  The application of carbon isotope ratio mass spectrometry to doping control. , 2008, Journal of mass spectrometry : JMS.

[391]  M. Thevis,et al.  Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing , 2011, Analytical and bioanalytical chemistry.

[392]  M. Huestis,et al.  Cannabis in Sport , 2011, Sports medicine.

[393]  D. Eichner,et al.  Detection of human insulin-like growth factor-1 in deer antler velvet supplements. , 2013, Rapid communications in mass spectrometry : RCM.

[394]  M. Thevis,et al.  Annual banned-substance review: analytical approaches in human sports drug testing. , 2012, Drug testing and analysis.

[395]  L. Ekström,et al.  Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[396]  M. Thevis,et al.  Emerging drugs: mechanism of action, mass spectrometry and doping control analysis. , 2009, Journal of mass spectrometry : JMS.

[397]  R. Gutiérrez-Gallego,et al.  Purification of erythropoietin from human plasma samples using an immunoaffinity well plate. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[398]  Giuseppe Banfi,et al.  Limits and pitfalls of Athlete's Biological Passport , 2011, Clinical chemistry and laboratory medicine.

[399]  A. Deligiannis,et al.  Cardiovascular adverse effects of doping in sports. , 2012, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[400]  Fabian Sanchis-Gomar,et al.  Current limitations of the Athlete's Biological Passport use in sports , 2011, Clinical chemistry and laboratory medicine.

[401]  J. V. Sancho,et al.  Comparison between triple quadrupole, time of flight and hybrid quadrupole time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. , 2011, Analytica chimica acta.

[402]  Determining the authenticity of athlete urine in doping control by DNA analysis. , 2015, Drug testing and analysis.

[403]  A. Baoutina,et al.  Improved detection of transgene and nonviral vectors in blood. , 2013, Human gene therapy methods.

[404]  H. Tobias,et al.  Comprehensive 2-dimensional gas chromatography fast quadrupole mass spectrometry (GC × GC-qMS) for urinary steroid profiling: mass spectral characteristics with chemical ionization. , 2011, Drug testing and analysis.

[405]  Fong-Ha Liu,et al.  Certification of steroid carbon isotope ratios in a freeze-dried human urine reference material. , 2012, Drug testing and analysis.

[406]  Helen Thompson Performance enhancement: Superhuman athletes , 2012, Nature.

[407]  H. Toriello,et al.  Gene doping: the hype and the harm. , 2010, Pediatric clinics of North America.

[408]  Ó. Pozo,et al.  Development and validation of an LC-MS/MS method for the quantification of ephedrines in urine. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[409]  P. Hemmersbach,et al.  Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters. , 2011, Drug testing and analysis.

[410]  Monica Mazzarino,et al.  Microwave irradiation for a fast gas chromatography-mass spectrometric analysis of polysaccharide-based plasma volume expanders in human urine. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[411]  M. Geraci,et al.  New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder , 2011, Human & experimental toxicology.

[412]  Ó. Pozo,et al.  Ultra high performance liquid chromatography tandem mass spectrometric detection of glucuronides resistant to enzymatic hydrolysis: Implications to doping control analysis. , 2015, Analytica chimica acta.

[413]  Lisi Zhang,et al.  Biomarker detection of rhGH doping: an excretion study. , 2012, Drug testing and analysis.

[414]  Serge Rudaz,et al.  A steroidomic approach for biomarkers discovery in doping control. , 2011, Forensic science international.

[415]  J. Schulze,et al.  Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests , 2009, Steroids.

[416]  A. Rogol Drugs of abuse and the adolescent athlete , 2010, Italian journal of pediatrics.

[417]  J. Ramsey,et al.  Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. , 2010, Journal of analytical toxicology.

[418]  Kuei-Hui Chan,et al.  Elimination of ephedrines in urine following administration of a Sho-seiryu-to preparation. , 2009, Journal of analytical toxicology.

[419]  M. Huestis,et al.  Current knowledge on cannabinoids in oral fluid. , 2014, Drug testing and analysis.

[420]  H. Geyer,et al.  Determination of (13)C/(12)C ratios of urinary excreted boldenone and its main metabolite 5beta-androst-1-en-17beta-ol-3-one. , 2010, Drug testing and analysis.

[421]  Ó. Pozo,et al.  Use of LC-MS/MS for the open detection of steroid metabolites conjugated with glucuronic acid. , 2013, Analytical chemistry.

[422]  A. Butch,et al.  Carbon isotope ratio mass spectrometry for detection of endogenous steroid use: a testing strategy. , 2013, Drug testing and analysis.

[423]  X. de la Torre,et al.  Reference ranges for the urinary steroid profile in a Latin-American population. , 2013, Drug testing and analysis.

[424]  Wilhelm Schänzer,et al.  Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. , 2009, Drug testing and analysis.

[425]  M. Mazzarino,et al.  Relevance of the selective oestrogen receptor modulators tamoxifen, toremifene and clomiphene in doping field: Endogenous steroids urinary profile after multiple oral doses , 2011, Steroids.

[426]  J. Mazanov Beyond antidoping and harm minimisation: a stakeholder-corporate social responsibility approach to drug control for sport , 2015, Journal of Medical Ethics.

[427]  H. Yoo,et al.  Simple and accurate quantitative analysis of seven prohibited threshold substances in human urine by liquid chromatography/tandem mass spectrometry in doping control. , 2011, Rapid communications in mass spectrometry : RCM.

[428]  S. Kageyama,et al.  Determination of mepitiostane metabolites in human urine by liquid chromatography/tandem mass spectrometry for sports drug testing. , 2015, Journal of pharmaceutical and biomedical analysis.

[429]  B. Wuyam,et al.  Effect of salbutamol on neuromuscular function in endurance athletes. , 2013, Medicine and science in sports and exercise.

[430]  Sébastien Anizan,et al.  The potential role of oral fluid in antidoping testing. , 2014, Clinical chemistry.

[431]  M. Thevis,et al.  Targeting prohibited substances in doping control blood samples by means of chromatographic–mass spectrometric methods , 2013, Analytical and Bioanalytical Chemistry.

[432]  V. Backer,et al.  Urine and Serum Concentrations of Inhaled and Oral Terbutaline , 2012, International Journal of Sports Medicine.

[433]  P. Dargan,et al.  Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone , 2010, Emergency Medicine Journal.

[434]  M. Thevis,et al.  Investigations of the microbial transformation of cortisol to prednisolone in urine samples , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[435]  G. Goldspink,et al.  Growth factors, muscle function, and doping. , 2010, Endocrinology and metabolism clinics of North America.

[436]  V. Backer,et al.  Urine Concentrations of Repetitive Doses of Inhaled Salbutamol , 2011, International journal of sports medicine.

[437]  Richard R Young,et al.  Overview of the legal framework applicable to the marker method for the detection of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[438]  V. Backer,et al.  Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations. , 2013, Medicine and science in sports and exercise.

[439]  N. Baume,et al.  Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. , 2011, Analytica chimica acta.

[440]  C. Lundby,et al.  Detection of EPO injections using a rapid lateral flow isoform test , 2013, Analytical and Bioanalytical Chemistry.

[441]  Charlotte Bell,et al.  Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. , 2011, Drug testing and analysis.

[442]  B. Saltin,et al.  The evolving science of detection of ‘blood doping’ , 2012, British journal of pharmacology.

[443]  Martial Saugy,et al.  Statistical discrimination of steroid profiles in doping control with support vector machines. , 2013, Analytica chimica acta.

[444]  Hazel Torrance,et al.  The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. , 2010, Forensic science international.

[445]  P. Sönksen,et al.  The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays. , 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[446]  M. Thevis,et al.  Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. , 2013, Rapid communications in mass spectrometry : RCM.

[447]  S. Kageyama,et al.  Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.

[448]  P. Simon,et al.  Principle considerations for the use of transcriptomics in doping research. , 2011, Drug testing and analysis.

[449]  W. Ni,et al.  Development and Utility of an Internal Threshold Control (ITC) Real-Time PCR Assay for Exogenous DNA Detection , 2012, PloS one.

[450]  Giuseppe Lippi,et al.  Preanalytical variability: the dark side of the moon in blood doping screening , 2010, European Journal of Applied Physiology.

[451]  M. Thevis,et al.  Storage‐induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high‐resolution/high‐accuracy MS , 2012, Proteomics.

[452]  K. Deventer,et al.  Prevalence of legal and illegal stimulating agents in sports , 2011, Analytical and bioanalytical chemistry.

[453]  H. Geyer,et al.  Seized designer supplement named “1-Androsterone”: Identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination , 2011, Steroids.

[454]  R. Plumb,et al.  A simple high pH liquid chromatography-tandem mass spectrometry method for basic compounds: application to ephedrines in doping control analysis. , 2011, Journal of chromatography. A.

[455]  R. Ventura,et al.  Detection methods for autologous blood doping. , 2012, Drug testing and analysis.

[456]  P. Marriott,et al.  Evaluation of World Anti-Doping Agency criteria for anabolic agent analysis by using comprehensive two-dimensional gas chromatography–mass spectrometry , 2010, Analytical and bioanalytical chemistry.

[457]  M. Saugy,et al.  Investigations on carbon isotope ratios and concentrations of urinary formestane. , 2012, Drug testing and analysis.

[458]  J. Crippa,et al.  Why should Cannabis be Considered Doping in Sports? , 2013, Front. Psychiatry.

[459]  L. Engebretsen,et al.  Therapeutic use of growth factors in the musculoskeletal system in sports-related injuries. , 2009, The Journal of sports medicine and physical fitness.

[460]  M. Saugy,et al.  Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples. , 2011, Forensic science international.

[461]  M. Thevis,et al.  Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[462]  M. Koupparis,et al.  Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin , 2010, Analytical and bioanalytical chemistry.

[463]  M. Koupparis,et al.  Stabilization of human urine doping control samples: II. microbial degradation of steroids. , 2009, Analytical biochemistry.

[464]  C. Gore,et al.  Stability of athlete blood passport parameters during air freight , 2014, International journal of laboratory hematology.

[465]  S. Brandt,et al.  AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis. , 2013, Drug testing and analysis.

[466]  Neil Robinson,et al.  The athlete's biological passport and indirect markers of blood doping. , 2010, Handbook of experimental pharmacology.

[467]  T. Pottgiesser,et al.  Current strategies of blood doping detection , 2013, Analytical and Bioanalytical Chemistry.

[468]  M. Flueck,et al.  A polymerase chain reaction-based methodology to detect gene doping , 2011, European Journal of Applied Physiology.

[469]  E. Tudela,et al.  Sensitive detection of 3'-hydroxy-stanozolol glucuronide by liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. A.

[470]  Chun-Chi Wang,et al.  Analysis of anabolic androgenic steroids in urine by full-capillary sample injection combined with a sweeping CE stacking method , 2013, Analytical and Bioanalytical Chemistry.

[471]  A. Leinonen,et al.  Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control. , 2013, Drug testing and analysis.

[472]  F. Kobarfard,et al.  Morphine/Codeine Ratio, a Key in Investigating a Case of Doping , 2015, Asian journal of sports medicine.

[473]  M. Thevis,et al.  Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing. , 2013, Methods in molecular biology.

[474]  Perikles Simon,et al.  A quantitative approach for assessing significant improvements in elite sprint performance: has IGF-1 entered the arena? , 2013, Drug testing and analysis.

[475]  M. Schwarcz,et al.  Growth Hormone and the Cardiovascular System , 2012, Cardiology in review.

[476]  K. George,et al.  Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician , 2012, British Journal of Sports Medicine.

[477]  C. Reichel Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control. , 2010, Drug testing and analysis.

[478]  J. O'Brien,et al.  'Smoking' mephedrone: the identification of the pyrolysis products of 4-methylmethcathinone hydrochloride. , 2013, Drug testing and analysis.

[479]  Ann I. Graul Peginesatide for the treatment of anemia in the nephrology setting. , 2012, Drugs of today.

[480]  D. Huckins,et al.  Myocardial ischemia associated with clenbuterol abuse: report of two cases. , 2013, The Journal of emergency medicine.

[481]  C. Cooper,et al.  Drug cheating at the Olympics: who, what, and why? , 2012, The Lancet.

[482]  M. Thevis,et al.  AOD-9604 does not influence the WADA hGH isoform immunoassay. , 2013, Drug testing and analysis.

[483]  Xiliang Luo,et al.  The label free picomolar detection of insulin in blood serum. , 2013, Biosensors & bioelectronics.

[484]  Martial Saugy,et al.  Endogenous steroid profiling in the athlete biological passport. , 2010, Endocrinology and metabolism clinics of North America.

[485]  P. Van Eenoo,et al.  Fast quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THCA) using microwave-accelerated derivatisation and gas chromatography-triple quadrupole mass spectrometry. , 2013, Forensic science international.

[486]  C. Goebel Stimulating luteinizing hormone. , 2011, Drug testing and analysis.

[487]  Martial Saugy,et al.  A pilot study on subject‐based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports , 2011, Clinical endocrinology.

[488]  P. Dargan,et al.  The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). , 2011, Drug testing and analysis.

[489]  Ó. Pozo,et al.  Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. , 2009, Drug testing and analysis.

[490]  G. Rodchenkov,et al.  Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE. , 2015, Drug testing and analysis.

[491]  Peter Prock,et al.  Supplements and inadvertent doping - how big is the risk to athletes. , 2012, Medicine and sport science.

[492]  T. Sobolevsky,et al.  Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine , 2012, The Journal of Steroid Biochemistry and Molecular Biology.

[493]  A. Butch,et al.  Detection of prohibited substances by liquid chromatography tandem mass spectrometry for sports doping control. , 2012, Methods in molecular biology.

[494]  Lisi Zhang,et al.  Detection of doping with rhGH: excretion study with WADA-approved kits. , 2011, Drug testing and analysis.

[495]  M. Thevis,et al.  Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience. , 2010, Drug testing and analysis.

[496]  M. Duclos,et al.  Why glucocorticoids ought to be kept on the World Antidoping Agency’s list of banned products , 2007, British Journal of Sports Medicine.

[497]  X. de la Torre,et al.  Metabolism of boldione in humans by mass spectrometric techniques: detection of pseudoendogenous metabolites. , 2013, Drug testing and analysis.

[498]  R. Borges,et al.  Salbutamol extraction from urine and its stability in different solutions: identification of methylation products and validation of a quantitative analytical method. , 2013, Biomedical chromatography : BMC.

[499]  J. Travis Pharmacology. Growth hormone test finally nabs first doper. , 2010, Science.

[500]  P. Sönksen,et al.  Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes. , 2013, Drug testing and analysis.

[501]  H. Haenssle,et al.  The dark side of beauty: acne fulminans induced by anabolic steroids in a male bodybuilder. , 2012, Archives of dermatology.

[502]  L. Lipshultz,et al.  Men regret anabolic steroid use due to a lack of comprehension regarding the consequences on future fertility , 2014, Andrologia.

[503]  J. Christiansen,et al.  Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[504]  H. Yoo,et al.  LC-ESI/MS/MS method for rapid screening and confirmation of 44 exogenous anabolic steroids in human urine , 2011, Analytical and bioanalytical chemistry.

[505]  S. Kageyama,et al.  Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[506]  M. Zorzoli The Athlete Biological Passport from the perspective of an anti-doping organization , 2011, Clinical chemistry and laboratory medicine.

[507]  M. Galésio,et al.  Matrix-assisted laser desorption/ionisation time of flight spectrometry for the fast screening of oxosteroids using aromatic hydrated hydrazines as versatile probes. , 2012, Talanta.

[508]  M. Thevis,et al.  Detection of testosterone esters in blood. , 2015, Drug testing and analysis.

[509]  S. Reiken,et al.  Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity , 2008, Proceedings of the National Academy of Sciences.

[510]  A. Butch,et al.  Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample. , 2013, Drug testing and analysis.

[511]  K. Graham,et al.  The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes , 2010, Annals of Internal Medicine.

[512]  M. Saugy,et al.  Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing , 2013, Analytical and Bioanalytical Chemistry.

[513]  D. Thieme,et al.  Urinary concentrations of ethyl glucuronide and ethyl sulfate as thresholds to determine potential ethanol-induced alteration of steroid profiles. , 2011, Drug testing and analysis.

[514]  Christopher R Harrison Role of capillary electrophoresis in the fight against doping in sports. , 2013, Analytical chemistry.

[515]  G. S. Bains,et al.  Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system , 2010, Gene Therapy.

[516]  E. Petricoin,et al.  Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH. , 2009, Drug testing and analysis.

[517]  J. Kurreck RNA Interference: From Basic Research to Therapeutic Applications , 2009, Angewandte Chemie.

[518]  H. Tobias,et al.  Steroid isotopic standards for gas chromatography-combustion isotope ratio mass spectrometry (GCC-IRMS) , 2009, Steroids.

[519]  Jingzhu Wang,et al.  Influences of musk administration on the doping test , 2013, Steroids.

[520]  P. Van Eenoo,et al.  An improved gas chromatography screening method for doping substances using triple quadrupole mass spectrometry, with an emphasis on quality assurance. , 2012, Biomedical chromatography : BMC.

[521]  M. Thevis,et al.  Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. , 2012, Drug testing and analysis.

[522]  S. Sánchez‐Cortés,et al.  Adsorption of beta-adrenergic agonists used in sport doping on metal nanoparticles: a detection study based on surface-enhanced Raman scattering. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[523]  M. Thevis,et al.  Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis. , 2009, Drug testing and analysis.

[524]  T. Kadowaki,et al.  Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity , 2015, Diabetes & metabolism journal.

[525]  K. Carlsen,et al.  Two distinct phenotypes of asthma in elite athletes identified by latent class analysis , 2015, The Journal of asthma : official journal of the Association for the Care of Asthma.

[526]  R. Wood,et al.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. , 2014, Endocrine reviews.

[527]  M. Saugy,et al.  Plasma and urine profiles of Δ9-tetrahydrocannabinol and its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes , 2010, Analytical and bioanalytical chemistry.

[528]  M. Thevis,et al.  Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry , 2015, Drug testing and analysis.

[529]  S. Annaheim,et al.  RhEPO improves time to exhaustion by non-hematopoietic factors in humans , 2016, European Journal of Applied Physiology.

[530]  Simone Esposito,et al.  Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products. , 2012, Rapid communications in mass spectrometry : RCM.

[531]  S. Rudaz,et al.  Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports , 2015, Analytical and Bioanalytical Chemistry.

[532]  A. Laggner,et al.  Hypokalemic paralysis in a professional bodybuilder. , 2012, The American journal of emergency medicine.

[533]  C. Georgakopoulos,et al.  Sports doping: emerging designer and therapeutic β2-agonists. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[534]  N. Robinson,et al.  Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport. , 2012, Drug testing and analysis.

[535]  M. Schäfer,et al.  Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control. , 2009, Rapid communications in mass spectrometry : RCM.

[536]  Wilhelm Schänzer,et al.  Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. , 2009, Drug testing and analysis.

[537]  F. Botrè,et al.  The abuse of diuretics as performance‐enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis , 2010, British journal of pharmacology.

[538]  M. Thevis,et al.  Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503. , 2009, Rapid communications in mass spectrometry : RCM.

[539]  M. Zorzoli,et al.  Case studies on ESA-doping as revealed by the Biological Passport. , 2012, Drug testing and analysis.

[540]  D. Hughes The World Anti-Doping Code in sport: Update for 2015. , 2015, Australian prescriber.

[541]  D. Cowan,et al.  Doping in sport: 3. Metabolic conversion of oral norethisterone to urinary 19-norandrosterone , 2009, Steroids.

[542]  Wilhelm Schänzer,et al.  Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. , 2012, Methods.

[543]  A. Sytkowski,et al.  Erythropoietin and erythropoiesis stimulating agents. , 2012, Drug testing and analysis.

[544]  M. Thevis,et al.  Detection of Surreptitious Administration of Analog Insulin to an 8-Week-Old Infant , 2010, Pediatrics.

[545]  K. Deventer,et al.  A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. , 2011, Journal of chromatography. A.

[546]  Saskia S Sterk,et al.  Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays. , 2009, Analytica chimica acta.

[547]  J. Naud,et al.  Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE. , 2013, Drug testing and analysis.

[548]  Liang Tang,et al.  Rapid and sensitive detection of β-agonists using a portable fluorescence biosensor based on fluorescent nanosilica and a lateral flow test strip. , 2013, Biosensors & bioelectronics.

[549]  M. Thevis,et al.  Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis. , 2015, Drug testing and analysis.

[550]  D. Thieme,et al.  Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control. , 2013, Drug testing and analysis.

[551]  Markus Parzeller,et al.  The punishment of gene doping - The relation between WADA prohibited lists, German Medicinal Products Act, German Doping Agents Amounts Ordinance, and Basic Law of the Federal Republic of Germany. , 2011, Drug testing and analysis.

[552]  F. Donati,et al.  A fast screening method for the detection of the abuse of hemoglobin-based oxygen carriers (HBOCs) in doping control. , 2010, Talanta.

[553]  R. Jacobs,et al.  Reticulocyte and haemoglobin profiles in elite triathletes over four consecutive seasons , 2011, International journal of laboratory hematology.

[554]  L. Freeman,et al.  Alternative medicine and doping in sports. , 2012, The Australasian medical journal.

[555]  Suzanne Fergus,et al.  Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues , 2011, Psychopharmacology.

[556]  F. R. A. Aquino Neto,et al.  Consequences of the formation of 3,4-dimethyl-5-phenyl-1,3-oxazolidine on the analysis of ephedrines in urine by gas chromatography and a new method for confirmation as N-trifluoroacetyl-O-t-butyldimethylsilyl ether derivatives. , 2011, Journal of chromatography. A.

[557]  S. Mosler,et al.  Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR , 2010, Molecular and Cellular Endocrinology.

[558]  P. J. Elliot,et al.  A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers , 2012, PloS one.

[559]  J. Segura,et al.  Tracking growth hormone abuse in sport: a comparison of distinct isoform-based assays. , 2012, Analytica chimica acta.

[560]  V. Martínez-Bello,et al.  PPARgamma agonist pioglitazone does not enhance performance in mice. , 2014, Drug testing and analysis.

[561]  S. Bermon,et al.  From Gene Engineering to Gene Modulation and Manipulation: Can We Prevent or Detect Gene Doping in Sports? , 2013, Sports Medicine.

[562]  N. Baume,et al.  Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[563]  F. Botrè,et al.  Development and validation of a GC-C-IRMS method for the confirmation analysis of pseudo-endogenous glucocorticoids in doping control. , 2015, Drug testing and analysis.

[564]  Martial Saugy,et al.  Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports. , 2010, Drug testing and analysis.

[565]  F. R. A. Aquino Neto,et al.  Systematic analysis of glycerol: colourimetric screening and gas chromatography-mass spectrometric confirmation. , 2015, Drug testing and analysis.

[566]  R. Wootton,et al.  The naphyrone story: The alpha or beta-naphthyl isomer? , 2010, Drug testing and analysis.

[567]  X. de la Torre,et al.  Urine stability and steroid profile: towards a screening index of urine sample degradation for anti-doping purpose. , 2011, Analytica chimica acta.

[568]  H. Geyer,et al.  Degradation of urine samples and its influence on the ¹³C/¹²C ratios of excreted steroids. , 2010, Drug testing and analysis.

[569]  P. Marriott,et al.  Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control. , 2010, Journal of chromatography. A.

[570]  M. Mascini,et al.  Affinity sensing for transgenes detection in antidoping control. , 2009, Analytical chemistry.

[571]  S. Sánchez‐Cortés,et al.  Adsorption and detection of sport doping drugs on metallic plasmonic nanoparticles of different morphology. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[572]  R. Di Santo,et al.  Mass spectrometric characterization of tamoxifene metabolites in human urine utilizing different scan parameters on liquid chromatography/tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[573]  B. Adams,et al.  Case reports: Death of active duty soldiers following ingestion of dietary supplements containing 1,3-dimethylamylamine (DMAA). , 2012, Military medicine.

[574]  J. Dvořák,et al.  Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? , 2013, Rapid communications in mass spectrometry : RCM.

[575]  N. Robinson,et al.  How to confirm C.E.R.A. doping in athletes' blood? , 2011, Forensic science international.

[576]  Daniel Umpierre,et al.  Increased atherothrombotic markers and endothelial dysfunction in steroid users , 2013, European journal of preventive cardiology.

[577]  M. Thevis,et al.  Identification of human pituitary growth hormone variants by mass spectrometry. , 2009, Journal of proteome research.

[578]  Vinod K. Gupta,et al.  A sensitive voltammetric sensor for determination of synthetic corticosteroid triamcinolone, abused for doping. , 2009, Biosensors & bioelectronics.

[579]  C. Saudan,et al.  Detection in urine of 4-methyl-2-hexaneamine, a doping agent. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[580]  Marilyn A Huestis,et al.  Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. , 2013, Analytical chemistry.

[581]  E. Tudela,et al.  In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200. , 2013, Rapid communications in mass spectrometry : RCM.

[582]  Martial Saugy,et al.  Blood transfusion in sports. , 2010, Handbook of experimental pharmacology.

[583]  M. Thevis,et al.  Analytical challenges in the detection of peptide hormones for anti-doping purposes. , 2012, Bioanalysis.

[584]  B. Friedmann-Bette,et al.  Dependence of hemoglobin mass estimation with the optimized CO‐rebreathing method on different spectrophotometers , 2012, Scandinavian journal of medicine & science in sports.

[585]  Ó. Pozo,et al.  Alternative long-term markers for the detection of methyltestosterone misuse , 2013, Steroids.

[586]  F. Lasne,et al.  The problem of anti-doping control of luteinizing hormone in boxing. , 2013, Drug testing and analysis.

[587]  J. Fisher Landmark advances in the development of erythropoietin , 2010, Experimental biology and medicine.

[588]  David T. Martin,et al.  Stability of Hemoglobin Mass During a 6-Day UCI ProTour Cycling Race , 2010, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[589]  E. Fornal Study of collision-induced dissociation of electrospray-generated protonated cathinones. , 2014, Drug testing and analysis.

[590]  N. Robinson,et al.  The fight against doping: back on track with blood. , 2009, Drug testing and analysis.

[591]  C J Gore,et al.  Quality control technique to reduce the variability of longitudinal measurement of hemoglobin mass , 2011, Scandinavian journal of medicine & science in sports.

[592]  A. George,et al.  Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control. , 2012, Drug testing and analysis.

[593]  M. Thevis,et al.  Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. , 2011, Rapid communications in mass spectrometry : RCM.

[594]  J. Orchard Why glucocorticoids should be removed from the World Antidoping Agency’s list of banned products , 2007, British Journal of Sports Medicine.

[595]  M. Mazzarino,et al.  A screening method for the simultaneous detection of glucocorticoids, diuretics, stimulants, anti-oestrogens, beta-adrenergic drugs and anabolic steroids in human urine by LC-ESI-MS/MS , 2008, Analytical and bioanalytical chemistry.

[596]  J. Delanghe,et al.  A rapid and simple assay to determine pegylated erythropoietin in human serum. , 2010, Journal of applied physiology.

[597]  Ó. Pozo,et al.  Alternative markers for the long-term detection of oral testosterone misuse , 2011, Steroids.

[598]  C. Buisson,et al.  Isotope ratio mass spectrometry analysis of the oxidation products of the main and minor metabolites of hydrocortisone and cortisone for antidoping controls , 2009, Steroids.

[599]  P. Thirumalaikolundusubramanian,et al.  Clinical, laboratory, and educational challenges of diuretic doping. , 2013, The American journal of emergency medicine.

[600]  G. Banfi,et al.  Reticulocytes in sports medicine: an update. , 2013, Advances in clinical chemistry.

[601]  D. Zuba,et al.  Prevalence and co-existence of active components of 'legal highs'. , 2013, Drug testing and analysis.

[602]  F. Lasne,et al.  Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control , 2009, Haematologica.

[603]  M. Hsu,et al.  Liquid chromatography-tandem mass spectrometry screening method for the simultaneous detection of stimulants and diuretics in urine. , 2011, Journal of analytical toxicology.

[604]  F. Botrè,et al.  Analysis of stimulants in oral fluid and urine by gas chromatography-mass spectrometry II: pseudophedrine. , 2010, Journal of analytical toxicology.

[605]  M. Thevis,et al.  Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS , 2013, Analytical and Bioanalytical Chemistry.

[606]  P. Prather,et al.  Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. , 2013, Toxicology and applied pharmacology.

[607]  M. Thevis,et al.  Plasticizers excreted in urine: indication of autologous blood transfusion in sports , 2012, Transfusion.

[608]  J. Rupert,et al.  Transcriptional profiling: a potential anti‐doping strategy , 2009, Scandinavian journal of medicine & science in sports.

[609]  M. Mehlman Genetic enhancement in sport: just another form of doping? , 2012, Recent patents on DNA & gene sequences.

[610]  M. Thevis,et al.  Seizures of doping substances at the Swiss Border--a descriptive investigation. , 2015, Forensic science international.

[611]  S. Horning,et al.  Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing. , 2013, Rapid communications in mass spectrometry : RCM.

[612]  A. Miah Genetics & sport: bioethical concerns. , 2012, Recent patents on DNA & gene sequences.

[613]  Ioulietta Erotokritou-Mulligan,et al.  The use of growth hormone (GH)‐dependent markers in the detection of GH abuse in sport: Physiological intra‐individual variation of IGF‐I, type 3 pro‐collagen (P‐III‐P) and the GH‐2000 detection score , 2010, Clinical endocrinology.

[614]  Y O Schumacher,et al.  Diurnal and exercise-related variability of haemoglobin and reticulocytes in athletes. , 2010, International journal of sports medicine.

[615]  C. Creaser,et al.  Application of mass spectrometry-based proteomics techniques for the detection of protein doping in sports , 2010, Expert review of proteomics.

[616]  L A King,et al.  Aminoindanes--the next wave of 'legal highs'? , 2011, Drug testing and analysis.

[617]  C. Buisson,et al.  Simultaneous quantification and qualification of synacthen in plasma , 2011, Analytical and bioanalytical chemistry.

[618]  P. Teale,et al.  Comparative in vitro metabolism of the ‘designer’ steroid estra-4,9-diene-3,17-dione between the equine, canine and human: Identification of target metabolites for use in sports doping control , 2010, Steroids.

[619]  M. Thevis,et al.  Mass spectrometric studies on the in vitro generated metabolites of SIRT1 activating drugs for doping control purposes. , 2013, Journal of mass spectrometry : JMS.

[620]  E. Yanes,et al.  High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[621]  J. Auwerx,et al.  Pharmacological approaches to restore mitochondrial function , 2013, Nature Reviews Drug Discovery.

[622]  F. Guan,et al.  Identification of Darbepoetin Alfa in Human Plasma by Liquid Chromatography Coupled to Mass Spectrometry for Doping Control , 2009, International journal of sports medicine.

[623]  M. Farré,et al.  Fit-for-Purpose Radio Receptor Assay for the Determination of Growth Hormone Secretagogues in Urine , 2015, Journal of biomolecular screening.

[624]  H. Geyer,et al.  Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[625]  Yu Bai,et al.  Applications of ambient mass spectrometry in high-throughput screening. , 2013, The Analyst.

[626]  U. Stenman,et al.  Loss of human chorionic gonadotropin in urine during storage at -20°C. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[627]  F. Botrè,et al.  A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[628]  O. Rabin,et al.  The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency. , 2011, Journal of analytical toxicology.

[629]  J. Veuthey,et al.  Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[630]  Shahram Mohaghegh,et al.  Doping and the Latest Prohibited List of the World Anti-Doping Agency (WADA) , 2013 .

[631]  C. Reichel,et al.  The interference of heparin on IEF-PAGE of erythropoietins. , 2010, Drug testing and analysis.

[632]  Günter Gmeiner,et al.  Defending Dynepo detection. , 2010, Drug testing and analysis.

[633]  G. Baumann Growth hormone doping in sports: a critical review of use and detection strategies. , 2012, Endocrine reviews.

[634]  J. Barbosa,et al.  Analysis of recombinant human erythropoietin glycopeptides by capillary electrophoresis electrospray-time of flight-mass spectrometry. , 2012, Analytica chimica acta.

[635]  K. Ho,et al.  Demographic factors influencing the GH system: Implications for the detection of GH doping in sport. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[636]  X. de la Torre,et al.  Analysis of exemestane and 17β-hydroxyexemestane in human urine by gas chromatography/mass spectrometry: development and validation of a method using MO-TMS derivatives. , 2010, Rapid communications in mass spectrometry : RCM.

[637]  M. Thevis,et al.  Mass spectrometric detection of siRNA in plasma samples for doping control purposes , 2010, Analytical and bioanalytical chemistry.

[638]  Ó. Pozo,et al.  Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment. , 2011, Drug testing and analysis.

[639]  I. Erotokritou-Mulligan,et al.  Insulin-like growth factor I and insulin and their abuse in sport. , 2010, Endocrinology and metabolism clinics of North America.

[640]  T. D. Gauthier Evidence for the Presence of 1,3-Dimethylamylamine (1,3-DMAA) in Geranium Plant Materials , 2013, Analytical chemistry insights.

[641]  J. McKenna,et al.  The search for size: a doping risk factor in adolescent rugby? , 2015, British Journal of Sports Medicine.

[642]  David E. Smith,et al.  The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis , 2015, Journal of psychoactive drugs.

[643]  P. Norsk,et al.  Mechanisms and Management of Exercise-Induced Asthma in Elite Athletes , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[644]  R. Bloomer,et al.  Physiological and pharmacokinetic effects of oral 1,3-dimethylamylamine administration in men , 2013, BMC Pharmacology and Toxicology.

[645]  J. Rupert,et al.  A DNA-based method for detecting homologous blood doping , 2013, Analytical and Bioanalytical Chemistry.

[646]  H. Haisma,et al.  Gene doping: an overview and current implications for athletes , 2013, British Journal of Sports Medicine.

[647]  D. Cowan,et al.  Doping in sport—1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone , 2009, Steroids.

[648]  Martial Saugy,et al.  Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion , 2013, PloS one.

[649]  S. Kageyama,et al.  Identification of the long-acting erythropoiesis-stimulating agent darbepoetin alfa in human urine by liquid chromatography–tandem mass spectrometry , 2014, Analytical and Bioanalytical Chemistry.

[650]  Y O Schumacher,et al.  The Impact of Acute Gastroenteritis on Haematological Markers Used for the Athletes Biological Passport – Report of 5 cases , 2010, International journal of sports medicine.

[651]  L. Ekström,et al.  Androgens and doping tests: genetic variation and pit-falls. , 2012, British journal of clinical pharmacology.

[652]  N. C. Sharp The human genome and sport, including epigenetics, gene doping, and athleticogenomics. , 2010, Endocrinology and metabolism clinics of North America.

[653]  J. V. Sancho,et al.  Detection and Characterization of a New Metabolite of 17α-Methyltestosterone , 2009, Drug Metabolism and Disposition.

[654]  M. Farré,et al.  Evaluation of the urinary threshold concentration of formoterol in sports drug testing. , 2013, Drug testing and analysis.

[655]  M. Saugy,et al.  Blood monitoring of perfluorocarbon compounds (F-tert-butylcyclohexane, perfluoromethyldecalin and perfluorodecalin) by headspace-gas chromatography-tandem mass spectrometry. , 2015, Talanta.

[656]  Roland P Archer,et al.  Reference materials for new psychoactive substances. , 2011, Drug testing and analysis.

[657]  D. B. Hibbert,et al.  Systematic comparison of δ13C measurements of testosterone and derivative steroids in a freeze-dried urine candidate reference material for sports drug testing by gas chromatography/combustion/isotope ratio mass spectrometry and uncertainty evaluation using four different metrological approaches. , 2011, Rapid communications in mass spectrometry : RCM.

[658]  P. Simon,et al.  A quick one-tube nested PCR-protocol for EPO transgene detection. , 2012, Drug testing and analysis.

[659]  F. Botrè,et al.  Investigation on the application of DNA forensic human identification techniques to detect homologous blood transfusions in doping control. , 2013, Talanta.

[660]  H. Tobias,et al.  Calibration and data processing in gas chromatography combustion isotope ratio mass spectrometry. , 2012, Drug testing and analysis.

[661]  M. Thevis,et al.  Screening for benfluorex and its major urinary metabolites in routine doping controls , 2011, Analytical and bioanalytical chemistry.

[662]  W. Schänzer,et al.  Metabolism of androsta-1,4,6-triene-3,17-dione and detection by gas chromatography/mass spectrometry in doping control. , 2009, Rapid communications in mass spectrometry : RCM.

[663]  C. Reichel SARCOSYL-PAGE: a new electrophoretic method for the separation and immunological detection of PEGylated proteins. , 2012, Methods in molecular biology.

[664]  Philippe Schmitt-Kopplin,et al.  Doping Control Using High and Ultra-High Resolution Mass Spectrometry Based Non-Targeted Metabolomics-A Case Study of Salbutamol and Budesonide Abuse , 2013, PloS one.

[665]  M. Baumstark,et al.  Gene expression in the detection of autologous blood transfusion in sports – a pilot study , 2009, Vox sanguinis.

[666]  C. Saudan,et al.  Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: international reference populations of professional soccer players , 2009, British Journal of Sports Medicine.

[667]  Wilhelm Schänzer,et al.  Doping control analysis of selected peptide hormones using LC-MS(/MS). , 2011, Forensic science international.

[668]  A. Didier,et al.  Medical and pharmacological approach to adjust the salbutamol anti-doping policy in athletes , 2015, Respiratory Research.

[669]  J. Carlsson,et al.  Ultra-sensitive immunochromatographic assay for quantitative determination of erythropoietin. , 2008, Journal of immunological methods.

[670]  Ying Dong,et al.  An improved liquid chromatography-tandem mass spectrometric method to quantify formoterol in human urine. , 2014, Journal of chromatographic science.

[671]  G. Baverel,et al.  Study of a new indirect method based on absolute norms of variation to detect autologous blood transfusion , 2008, International journal of hematology.

[672]  O. Rabin,et al.  Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administration of pseudoephedrine-containing medications to healthy subjects: implications for doping control analysis of these stimulants banned in sport. , 2012, Drug testing and analysis.

[673]  M. Bidlingmaier,et al.  Detecting growth hormone abuse in athletes. , 2005, Endocrinology and metabolism clinics of North America.

[674]  R. Damsgaard,et al.  Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers , 2011, Scandinavian journal of medicine & science in sports.

[675]  M. Nielen,et al.  Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[676]  A. Hoofnagle,et al.  Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. , 2014, Clinical chemistry.

[677]  A. Kubatiev,et al.  High-temperature high-performance liquid chromatography on a porous graphitized carbon column coupled to an Orbitrap mass spectrometer with atmospheric pressure photoionization for screening exogenous anabolic steroids in human urine. , 2015, Rapid communications in mass spectrometry : RCM.

[678]  C. Georgakopoulos,et al.  Examination of the kinetic isotopic effect to the acetylation derivatization for the gas chromatographic-combustion-isotope ratio mass spectrometric doping control analysis of endogenous steroids. , 2012, Drug testing and analysis.

[679]  V. Kouloulias,et al.  Pheromones: a new ergogenic aid in sport? , 2015, International journal of sports physiology and performance.

[680]  David A Cowan,et al.  Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control. , 2013, Journal of chromatography. A.

[681]  R. Oberhoffer,et al.  Gene expression profiling in human whole blood samples after controlled testosterone application and exercise. , 2011, Drug testing and analysis.

[682]  K. Patrick Passport to clean competition , 2012, BMJ : British Medical Journal.

[683]  F. Lasne,et al.  Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future. , 2012, Bioanalysis.

[684]  H. Tobias,et al.  Highly sensitive and selective analysis of urinary steroids by comprehensive two-dimensional gas chromatography combined with positive chemical ionization quadrupole mass spectrometry. , 2012, The Analyst.

[685]  P. Van Eenoo,et al.  beta-Adrenergic stimulation. , 2010, Handbook of experimental pharmacology.

[686]  S. Catalano,et al.  Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation , 2012, Molecular and Cellular Endocrinology.

[687]  S. Shuster,et al.  The banning of sportsmen and women who fail drug tests is unjustifiable. , 2013, The journal of the Royal College of Physicians of Edinburgh.

[688]  T. Sobolevsky,et al.  Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. , 2012, Drug testing and analysis.

[689]  G. Lippi,et al.  Telmisartan as metabolic modulator: a new perspective in sports doping? , 2012, Journal of strength and conditioning research.

[690]  Jorge Hallak,et al.  Anabolic steroids and male infertility: a comprehensive review , 2011, BJU international.

[691]  J. Grosse,et al.  Olodaterol and vilanterol detection in sport drug testing. , 2015, Drug testing and analysis.

[692]  S. Kageyama,et al.  UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse. , 2013, Drug testing and analysis.

[693]  W. Schänzer,et al.  Effects of High Intensity Exercise on Isoelectric Profiles and SDS-PAGE Mobility of Erythropoietin , 2010, International journal of sports medicine.

[694]  F. Buiarelli,et al.  Determination of nandrolone metabolites in human urine: comparison between liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[695]  F. Arioli,et al.  Presence of endogenous prednisolone in human urine , 2013, Steroids.

[696]  T. Wan,et al.  Controlling the misuse of cobalt in horses. , 2015, Drug testing and analysis.

[697]  M. Finel,et al.  UDP-Glucuronosyltransferases (UGTs) 2B7 and UGT2B17 Display Converse Specificity in Testosterone and Epitestosterone Glucuronidation, whereas UGT2A1 Conjugates Both Androgens Similarly , 2009, Drug Metabolism and Disposition.

[698]  J. Segura,et al.  Surface plasmon resonance immuno assays - A perspective. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[699]  E. Petricoin,et al.  Analysis of urinary human growth hormone (hGH) using hydrogel nanoparticles and isoform differential immunoassays after short recombinant hGH treatment: preliminary results. , 2013, Journal of pharmaceutical and biomedical analysis.

[700]  M. Thevis,et al.  Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. , 2012, Drug testing and analysis.

[701]  Tim James,et al.  Ultrasensitive label free electrical detection of insulin in neat blood serum. , 2013, Analytical chemistry.

[702]  P. Hemmersbach,et al.  Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. , 2010, Drug testing and analysis.

[703]  M. Thevis,et al.  The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs) , 2013, Xenobiotica; the fate of foreign compounds in biological systems.

[704]  P. Van Eenoo,et al.  The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione , 2009, Drug Metabolism and Disposition.

[705]  J. Coombes,et al.  Glycerol use in hyperhydration and rehydration: scientific update. , 2012, Medicine and sport science.

[706]  N. Ntoumanis,et al.  What if it really was an accident? The psychology of unintentional doping , 2015, British Journal of Sports Medicine.

[707]  M. Thevis,et al.  Detection of the protease bacillolysin in doping-control urine samples. , 2009, Drug testing and analysis.

[708]  T. Chapman,et al.  Drug testing data from the 2007 Pan American Games: δ 13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[709]  F. Botrè,et al.  A rapid screening LC-MS/MS method based on conventional HPLC pumps for the analysis of low molecular weight xenobiotics: application to doping control analysis. , 2010, Drug testing and analysis.

[710]  Ying Dong,et al.  Mass spectrometric identification and characterization of new fluoxymesterone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry , 2012, Steroids.

[711]  S. Lamon,et al.  Rapid affinity purification of erythropoietin from biological samples using disposable monoliths. , 2010, Journal of chromatography. A.

[712]  S. Shuster,et al.  Testing athletes, and banning those who take drugs, is unjustifiable , 2012, BMJ : British Medical Journal.

[713]  Ilkka Ojanperä,et al.  A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine , 2013, Analytical and Bioanalytical Chemistry.

[714]  Giuseppe Lippi,et al.  Altitude exposure in sports: the Athlete Biological Passport standpoint. , 2014, Drug testing and analysis.

[715]  H. Geyer,et al.  Determination of 13C/12C ratios of urinary epitestosterone and its main metabolites 5alpha- and 5beta-androstane-3alpha, 17alpha-diol. , 2009, Drug testing and analysis.

[716]  W. Schänzer,et al.  Optimizing SAR-PAGE. , 2015, Drug testing and analysis.

[717]  M. Uhl,et al.  Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry. , 2014, Drug testing and analysis.

[718]  P. Sönksen,et al.  GH & IGF Research issue on doping with growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[719]  M. Penaud-Budloo,et al.  Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping , 2011, Gene Therapy.

[720]  M. Thevis,et al.  Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.

[721]  J. Muñoz-Guerra,et al.  Use of hydrogen as a carrier gas for the analysis of steroids with anabolic activity by gas chromatography-mass spectrometry. , 2011, Journal of chromatography. A.

[722]  Carol S. Lim,et al.  The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications. , 2011, Journal of analytical toxicology.

[723]  R. D. Blackledge Bad science: the instrumental data in the Floyd Landis case. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[724]  P. Restani,et al.  Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin? , 2013, Drug testing and analysis.

[725]  Gangfeng Ouyang,et al.  Simultaneous analysis of fourteen tertiary amine stimulants in human urine for doping control purposes by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry. , 2010, Analytica chimica acta.

[726]  Ray H. Liu,et al.  Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis. , 2010, Journal of analytical toxicology.

[727]  Ó. Pozo,et al.  A new sulphate metabolite as a long-term marker of metandienone misuse , 2013, Steroids.

[728]  K. Ho,et al.  Growth hormone and physical performance , 2011, Trends in Endocrinology & Metabolism.

[729]  H. Sachs,et al.  Ethylglucuronide as a potential marker for alcohol-induced elevation of urinary testosterone/epitestosterone ratios. , 2009, Drug testing and analysis.

[730]  J. Savulescu,et al.  Should athletes be allowed to use performance enhancing drugs? , 2013, BMJ.

[731]  S. Lamon,et al.  Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues. , 2010, Journal of pharmaceutical and biomedical analysis.

[732]  N. Robinson,et al.  Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes. , 2010, Clinical laboratory.

[733]  M. Thevis,et al.  Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. , 2015, Drug testing and analysis.

[734]  G. Hoyer,et al.  Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[735]  M. Padilha,et al.  Study of the endogenous steroid profile of male athletes from the Brazilian National Soccer Championship 2009. , 2010, Drug testing and analysis.

[736]  V. Backer,et al.  Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes. , 2014, Drug testing and analysis.

[737]  M. Thevis,et al.  Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. , 2011, Drug testing and analysis.

[738]  Jingzhu Wang,et al.  Profiling of urinary steroids by gas chromatography–mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry , 2011, Steroids.

[739]  M. Thevis,et al.  Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO. , 2013, Journal of pharmaceutical and biomedical analysis.

[740]  M. Gütschow,et al.  In vitro synthesis and characterisation of three fenoterol sulfoconjugates detected in fenoterol post-administration urine samples , 2013, Analytical and Bioanalytical Chemistry.

[741]  P. Teale,et al.  Impact of the emergence of designer drugs upon sports doping testing , 2009 .

[742]  Keith Baar,et al.  Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases , 2012, Cell.